Cargando…
Efficacy of Olanzapine in Anxiety Dimension of Schizophrenia: A Systematic Review of Randomized Controlled Trials
Anxiety symptoms and anxiety disorders are frequent in patients with schizophrenia and are associated with greater severity of both positive and negative symptoms, cognitive impairment, poorer functioning and quality of life. Accumulating evidence suggests that atypical antipsychotics may have a rol...
Autores principales: | Crapanzano, Calogero, Casolaro, Ilaria, Damiani, Stefano, Amendola, Chiara |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean College of Neuropsychopharmacology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9606435/ https://www.ncbi.nlm.nih.gov/pubmed/36263635 http://dx.doi.org/10.9758/cpn.2022.20.4.592 |
Ejemplares similares
-
Quetiapine Treatment for Post-traumatic Stress Disorder: A Systematic Review of the Literature
por: Crapanzano, Calogero, et al.
Publicado: (2023) -
Lithium and Valproate in Bipolar Disorder: From International Evidence-based Guidelines to Clinical Predictors
por: Crapanzano, Calogero, et al.
Publicado: (2022) -
Clinical perspective on antipsychotic receptor binding affinities
por: Crapanzano, Calogero, et al.
Publicado: (2021) -
A Randomized Controlled Trial to Compare the Efficacy, Safety and Tolerability of Asenapine versus Olanzapine in Management of Schizophrenia
por: Maitra, Arpita, et al.
Publicado: (2020) -
Application of Plasma Levels of Olanzapine and N-Desmethyl-Olanzapine to Monitor Clinical Efficacy in Patients with Schizophrenia
por: Lu, Mong-Liang, et al.
Publicado: (2016)